Considering the Next Horizon of CLTI Trials
With BEST-CLI and BASIL-2 now complete, physicians contemplate the next phase of CLTI trials, including areas of focus and predictions for the most clinically impactful data.
With Marianne Brodmann, MD; Kumar Madassery, MD, FSIR; Sabine Steiner, MD; Zola N’Dandu, MD, FSCAI; and Matthew Menard, MD
